Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[A case of severe enteritis induced by adjuvant chemotherapy for colon cancer].

Mukai S, Endo S, Nakahara K, Takayanagi D, Maeda C, Takehara Y, Omoto T, Wada Y, Kida H, Hidaka E, Ishida F, Tanaka J, Kudo SE.

Gan To Kagaku Ryoho. 2014 Apr;41(4):499-502. Japanese.

PMID:
24743369
2.

[A case of sigmoid colon cancer in a patient undergoing hemodialysis treated by tegafur/uracil/folinate].

Miyazawa T, Chida T, Hasegawa S, Iwafuchi Y, Kamimura A, Watanabe G.

Gan To Kagaku Ryoho. 2008 Jan;35(1):149-51. Japanese.

PMID:
18195547
3.

Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.

Lembersky BC, Wieand HS, Petrelli NJ, O'Connell MJ, Colangelo LH, Smith RE, Seay TE, Giguere JK, Marshall ME, Jacobs AD, Colman LK, Soran A, Yothers G, Wolmark N.

J Clin Oncol. 2006 May 1;24(13):2059-64.

4.

[A case of unresectable colon cancer responding to oral leucovorin+oral tegafur/uracil].

Saito N, Ohata M, Ishii H, Ohori M, Tokura Y, Maruyama M, Furukawa T, Sato H.

Gan To Kagaku Ryoho. 2007 Aug;34(8):1287-90. Japanese.

PMID:
17687215
5.

Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.

Cellier P, Leduc B, Martin L, ViƩ B, Chevelle C, Vendrely V, Salemkour A, Carrie C, Calais G, Burtin P, Campion L, Boisdron-Celle M, Morel A, Berger V, Gamelin E.

BMC Cancer. 2011 Mar 16;11:98. doi: 10.1186/1471-2407-11-98.

6.
7.
8.

[Compliance of oral UFT plus leucovorin adjuvant chemotherapy in patients who underwent curative resection for colorectal cancer].

Tsunoda A, Nakao K, Watanabe M.

Gan To Kagaku Ryoho. 2010 Jun;37(6):1065-8. Japanese.

PMID:
20567109
9.

Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.

Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL.

J Clin Oncol. 2004 Sep 1;22(17):3466-74. Epub 2004 Jul 26.

10.

[A case report--combination chemotherapy with oral UFT and CPT-11, 5-FU, l-LV by hepatic arterial infusion for multiple hepatic metastasis from sigmoid colon cancer].

Kubo H, Kanekiyo S, Watanabe Y, Tada K, Hasegawa H.

Gan To Kagaku Ryoho. 2007 Dec;34(13):2313-6. Japanese.

PMID:
18079638
11.

Clinical compliance with an oral uracil/tegafur (UFT) plus leucovorin (LV) regimen as adjuvant chemotherapy in Japanese colorectal cancer patients.

Meguro M, Furuhata T, Okita K, Nishidate T, Ishiyama G, Iwayama Y, Kimura Y, Mizuguchi T, Hirata K.

Int J Clin Oncol. 2009 Oct;14(5):402-7. doi: 10.1007/s10147-009-0888-1. Epub 2009 Oct 25.

PMID:
19856047
12.

Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule.

Pazdur R, Lassere Y, Diaz-Canton E, Bready B, Ho DH.

Invest New Drugs. 1997;15(2):123-8.

PMID:
9220291
13.

Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.

Hoff PM, Janjan N, Saad ED, Skibber J, Crane C, Lassere Y, Cleary KR, Benner S, Randolph J, Abbruzzese JL, Pazdur R.

J Clin Oncol. 2000 Oct 15;18(20):3529-34.

PMID:
11032595
14.

[A case of liver metastases of sigmoid colon cancer treated effectively by oral UFT/LV].

Yamamoto D, Bando H, Matsunaga M, Ishiyama Y, Kaneko M, Yamamoto M, Kotake M, Inaki N, Kurokawa M, Yamada T.

Gan To Kagaku Ryoho. 2012 Aug;39(8):1263-5. Japanese.

PMID:
22902455
15.

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.

Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV Jr, Markowitz AB, Abbruzzese JL, Bready B, et al.

J Clin Oncol. 1994 Nov;12(11):2296-300.

PMID:
7964943
16.

[A case of early gastric cancer responding to adjuvant chemotherapy for treatment of colon cancer].

Saito A, Murakami M, Suzuki S, Sagane M, Hayashi T, Enosawa T, Murai N, Yoshizawa H, Mochizuki K, Fukushima M, Yokokawa H.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2271-3. Japanese.

PMID:
24394082
17.

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial.

Mochizuki I, Takiuchi H, Ikejiri K, Nakamoto Y, Kinugasa Y, Takagane A, Endo T, Shinozaki H, Takii Y, Takahashi Y, Mochizuki H, Kotake K, Kameoka S, Takahashi K, Watanabe T, Watanabe M, Boku N, Tomita N, Matsubara Y, Sugihara K.

Br J Cancer. 2012 Mar 27;106(7):1268-73. doi: 10.1038/bjc.2012.86. Epub 2012 Mar 13.

18.

[Multiple liver metastases due to sigmoid colon cancer successfully treated by degradable starch microspheres (DSM)-TAE, radiofrequency ablation therapy, and Uzel/UFT].

Ishikawa T, Higuchi K, Kubota T, Seki K, Ohta H, Yoshida T, Kamimura T.

Gan To Kagaku Ryoho. 2010 Feb;37(2):335-8. Japanese.

PMID:
20154497
19.

Life-threatening toxicity of oral tegafur-uracil (UFT) plus leucovorin.

Ribas A, Gallardo E, Vera R, Casado S, Vidal R, Bellmunt J.

Clin Oncol (R Coll Radiol). 1997;9(4):269-70.

PMID:
9315406
Items per page

Supplemental Content

Write to the Help Desk